BWP
CELU icon

Baldwin Wealth Partners’s Celularity CELU Stock Holding History

Baldwin Wealth Partners’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-11
Closed -$24 – 732
2023
Q3 		$24 Hold
11
– – ﹤0.01% 754
2023
Q2 		$59 Hold
11
– – ﹤0.01% 765
2023
Q1 		$68 Buy
+11
New +$89 ﹤0.01% 799

Other funds holding CELU

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFO
Biltmore Family Office Charlotte, North Carolina $761M AUM 31.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
IIA
IPG Investment Advisors San Diego, California $696M AUM 46.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Baldwin Wealth Partners's CELU Position: Q4 2023 in Review

Baldwin Wealth Partners sold out of Celularity (CELU) in Q4 2023, closing a stake of 11 shares — an estimated $24 sold.

Baldwin Wealth Partners first reported a position in CELU in Q1 2023 and held it in 3 quarters. The position peaked at $68 in Q1 2023. 37 funds tracked by Wall St. Rank hold CELU as of Q4 2023.

  • Baldwin Wealth Partners reported no remaining Celularity position as of Q4 2023 after selling out during the quarter.
  • Baldwin Wealth Partners sold 11 Celularity shares in Q4 2023, an estimated $24.
  • Baldwin Wealth Partners first reported a position in Celularity in Q1 2023 and held it in 3 quarters.
  • Baldwin Wealth Partners's Celularity position peaked at $68 in Q1 2023.
  • 37 funds tracked by Wall St. Rank held Celularity as of Q4 2023.

Based on Baldwin Wealth Partners's 13F filing for Q4 2023, filed 8 Jan 2024.